Overexpression of HCG18 promotes osteosarcoma cell proliferation by augmenting aerobic glycolysis through regulation of the miR-365a-3p/PGK1 axis, suggesting that HCG18 may serve as a promising therapeutic target for osteosarcoma intervention 49. This evidence concerns the gene PGK1 and osteosarcoma.